In addition, Moody’s affirmed its “A2” rating on BVRHC’s outstanding bonds.
The assignment is a result of several factors, including the health center’s strong balance sheet, healthy operating performance, dominant market share and favorable service area. Moody’s also acknowledged BVRHC’s modest size, above average investments in less liquid hedge funds and high operating leverage.
The outlook is stable, reflecting Moody’s expectation that the health system will maintain its healthy balance sheet and strong operating performance.
More articles on healthcare finance:
Why Harvard’s $37B endowment is at risk of mediocrity
12 hospitals seeking RCM talent
Irving family presents record $700M bequest to NewYork-Presbyterian, Columbia University
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
